Stage IIIC Rectal Cancer Active Not Recruiting Phase 1 Trials for Oxaliplatin (DB00526)

IndicationStatusPhase
DBCOND0028694 (Stage IIIC Rectal Cancer)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02270606Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal CancerTreatment
NCT01643499Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal MalignanciesTreatment